One of the emerging trends that the Irish Medtech Strategy 2026–2029 highlights is ‘Market access shifts’. European and Irish procurement systems are shifting toward outcome-based purchasing models that reward efficiency, innovation, and demonstrable impact. This is set against a changing regulatory landscape, along with supply chain shifts, and growing demands.
That is why we are bringing members together to explore market access in Ireland, strategies for fostering innovation adoption in the health system, along with exploring how the European Health Technology Assessment Regulation is impacting businesses.
Speakers
• Medtech Senior Executive Ciara Finlay on the industry, health characteristics in Ireland, and the evolution of the health system
• HSE Assistant National Director , Sláintecare Transformation and Innovation Office Louise O’Hare on eTenders and the new innovation framework
• Health Innovation Hub, Senior Clinical Research Manager Dr Michael Twomey, on how businesses are solving healthcare challenges, and getting innovation into the health system
• EU Commission, DG SANTE, Senior Policy Officer and Team Leader for Health Technology Assessment (HTA) Dr Leslie Pibouleau, on the EU HTA Regulation in practice and what it means for business
More to be announced.